Inkef logo

Inkef

Europe, Noord-Holland, The Netherlands, Amsterdam

Description

Inkef focuses on early-stage venture investing in European companies active in technology and healthcare.

Investor Profile

Inkef has made 79 investments, with 3 in the past 12 months and 51% as lead.

Stage Focus

  • Series A (44%)
  • Series B (25%)
  • Seed (10%)
  • Series Unknown (9%)
  • Series C (4%)
  • Post Ipo Equity (3%)
  • Series E (1%)
  • Grant (1%)
  • Series D (1%)
  • Corporate Round (1%)

Country Focus

  • The Netherlands (58%)
  • United States (15%)
  • Germany (6%)
  • Denmark (6%)
  • Switzerland (6%)
  • Belgium (3%)
  • Finland (3%)
  • United Kingdom (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Software
  • Medical Device
  • Artificial Intelligence (Ai)
  • Information Technology
  • Financial Services
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Inkef frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 4
Invest-NL
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 4
BioGeneration Ventures
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 4
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 6
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 10
Mission BioCapital
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 4
Gilde Healthcare
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 6
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 7
Oxford Science Enterprises
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 4

Which angels does Inkef often collaborate with?

GR
North America, California, United States, San Francisco
Shared Deals: 1
FC
North America, Florida, United States, Boca Raton
Shared Deals: 1
LF
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
Dave Marver
North America, Washington, United States, Seattle
Shared Deals: 1
JB
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
Shared Deals: 1
JG
North America, California, United States, San Francisco
Shared Deals: 1
GC
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
RO
North America, Iowa, United States, Des Moines
Shared Deals: 1
KD
Europe, Vaud, Switzerland
Shared Deals: 1

What are some of recent deals done by Inkef?

Draupnir Bio

Risskov, Midtjylland, Denmark

Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.

BiotechnologyHealth CarePharmaceuticalTherapeutics
SeedJul 17, 2024
Amount Raised: $13,198,813
iOnctura

Genève, Geneve, Switzerland

iOnctura is a clinical-stage biotechnology company that specializes in developing treatments for cancer.

BiotechnologyHealth CareMedical DevicePharmaceutical
Series BJun 20, 2024
Amount Raised: $85,897,462
Provable Markets

New York, New York, United States

Provable Markets provides a secure platform for cash and synthetic equity finance trading through its ATS, Aurora.

FinanceFinancial ServicesTrading Platform
Series AMay 8, 2024
Amount Raised: $8,000,000
Onward

Eindhoven, Noord-Brabant, The Netherlands

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

BiotechnologyHealth CareMachinery ManufacturingMedicalMedical DeviceTherapeutics
Post Ipo EquityMar 20, 2024
Amount Raised: $21,875,113
Silverflow

Amsterdam, Noord-Holland, The Netherlands

Silverflow is a payment processing technology company that provides direct card-network access to payment service providers.

Financial ServicesFinTechInformation TechnologyPayments
Series ANov 16, 2023
Amount Raised: $16,279,804
NMD Pharma

Risskov, Midtjylland, Denmark

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

MedicalPharmaceuticalTherapeutics
Series BNov 15, 2023
Amount Raised: $81,409,005
Anavo Therapeutics

Leiden, Zuid-Holland, The Netherlands

Anavo Therapeutics provides therapeutic potential of human phosphatase biology.

BiotechnologyLife ScienceTherapeutics
SeedMay 2, 2023
Amount Raised: $9,358,986
QurAlis

Cambridge, Massachusetts, United States

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

BiotechnologyGeneticsHealth CarePrecision MedicineTherapeutics
Series BMar 9, 2023
Amount Raised: $88,000,000
Quantum Motion

London, England, United Kingdom

Quantum Motion is building a universal quantum computer in Silicon, using CMOS compatible processes.

ElectronicsHardwareQuantum Computing
Series BFeb 21, 2023
Amount Raised: $50,858,233
Happeo

Helsinki, Southern Finland, Finland

Happeo is a next-gen intranet that keeps teams informed, aligned, and productive

Cloud ComputingGoogleHuman ResourcesOnline PortalsSoftware
Series BJul 7, 2022
Amount Raised: $26,000,000